JP Morgan 2025: Guardant reports $737m in preliminary full-year revenue
Guardant Health has reported preliminary full-year 2024 revenues of $737m, reflecting year-over-year (YOY) growth of 31%, during an investor presentation …
Post
-
-
JP Morgan 2025: Dexcom shares up 5% after 2025 outlook forecasts $4.6bn in revenue
Dexcom has shaken off the lower sales outlook that plagued its share price in 2024 as the diabetes device developer …
-
Explainer: Is the UK’s AI blueprint Britain’s path to productivity or simply AI lip service?
The UK government’s blueprint to turbocharge the country’s AI capabilities, announced today (13 Jan), forms a cornerstone of its mission …
-
FDA approves Zeiss Medical Technology’s MEL 90 excimer laser
The US Food and Drug Administration (FDA) has approved Zeiss Medical Technology’s MEL 90 excimer laser technology. MEL 90 is integrated …
-
Illumina and Regeneron invest $139.5m in Truveta to build largest genetic database
DNA sequencing company Illumina and biotech Regeneron have invested in electronic health record data company Truveta to create the largest …
-
Researchers find ctDNA test predicts lung cancer outcomes in study
Researchers from various institutes, along with US biotech company Personalis, have found a test that can predict lung cancer outcomes …
-
JP Morgan 2025: NVIDIA partners with IQVIA, Illumina and Mayo Clinic
In moves that continue to strengthen its affiliation with the healthcare industry, NVIDIA has added three new companies to its …
-
Medtronic nets CE mark for Parkinson’s adaptive deep brain stimulation system
Medtronic has received CE marks under the European Union’s Medical Device Regulation (EU MDR) for the BrainSense adaptive deep brain …
-
Saluda Medical secures $100m for Evoke System commercialisation
Saluda Medical has completed a $100m financing round to further the commercialisation of its “Evoke System”. The investment was spearheaded by …
-
Johnson & Johnson MedTech’s Dual Energy Catheter gains CE mark approval
Johnson & Johnson MedTech’s Dual Energy THERMOCOOL SMARTTOUCH SF Catheter has gained the European CE mark approval for treating cardiac …
-
Revvity wins FDA clearance for ChLIA assay in free testosterone measurement
The US Food and Drug Administration (FDA) has cleared Revvity’s automated chemiluminescence-based immunoassay (ChLIA) test for free testosterone. The authorisation by …
-
Kindeva and Emervax partner to develop vaccine administration solution
Kindeva Drug Delivery and Emervax have partnered to co-develop a vaccine delivery solution for a range of viruses. The partnership gives …
-
OXcan raises $11m to develop liquid biopsy tests for early cancer detection
Oxford Cancer Analytics (OXcan) has secured $11m in Series A funding for the development of its liquid biopsy blood tests …
-
Qiagen scoops FDA clearance for gastrointestinal panel
Qiagen has received clearance from the US Food and Drug Administration (FDA) for the first in a planned series of …
-
FDA grants 510(k) clearance to Ventris Medical’s Backpack for orthopaedic use
The US Food and Drug Administration (FDA) has granted 510(k) clearance to Ventris Medical’s Backpack (Porous Biologic Scaffold, K240765) for …
